NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ViaLase

ViaLase

Private
Aliso Viejo, CaliforniaHealthcare & Life Scienceshttps://www.vialase.com/

Last Round

Series C

Apr 1, 2024

Total Funding Raised

$75.4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ViaLase is a medical technology company that develops a non-invasive, image-guided femtosecond laser surgical system for the treatment of open-angle glaucoma.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Keywords

glaucoma treatmentfemtosecond lasernoninvasive glaucoma treatmentimage-guided surgerytrabeculotomyFLigHTminimally invasive glaucoma surgeryMIGSprimary open-angle glaucomaPOAGophthalmologyglaucoma laserlaser trabeculotomymedical devicemedtechintraocular pressuresurgical laser

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ViaLase Comps

Public and private peers based on sector, stage, and business model.

ViaLase comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ViaLase Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CApr 1, 2024
SeedJan 18, 2024
Series BNov 1, 2021
Series AApr 1, 2019

Key People

Founding team and executive leadership

Tibor Juhasz

Chief Executive Officer

Executive Team

ViaLase Investors

Notable investors and investment history

ViaLase investors
InvestorRounds
Arboretum VenturesSeries C, Series B
Venture Investors Health FundSeries C
Venture Investors LLCSeed, Series B, Series A
Falcon VisionSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2026

    Presenting new scientific research at the 2026 ARVO Annual Meeting.

  • Jan 18, 2024

    $2.3M raised in Seed round.

ViaLase Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ViaLase Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ViaLase's valuation, stock price, and market status.

Firmographic Details

HeadquartersAliso Viejo, California
Employee Range33
Year Founded2019
Last FundingApr 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.